PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “POLIOMYELITIS/immunity”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources
PubMed1952

Complement-fixing antibodies to type 2 (Lansing) poliomyelitis virus in a normal population of a subtropical area.

Sera collected in 1950 from the native population in the vicinity of Cairo, Egypt, have been tested for complement-fixing antibodies to Type 2 (Lansing) poliomyelitis virus. Complement-fixing antibodies are confined to the age of 1 to 9 years if a serum dilution of 1:4 is used in the test, or to the age of 1 to 4 years with a serum dilution of 1:16. A comparison has been made of the findings obtained in this study with the results for neutralizing antibodies previously reported. Complement-fixing antibodies were found to be temporary in nature while neutralizing antibodies were maintained for long periods of time. On this basis, criteria for "recent," "old," or "no infection" in poliomyelitis have been established. Sixteen of the children were bled again in 1952, 18 months after the first bleeding and both series of sera were compared in complement fixation and neutralization tests. All children who were negative in 1950 and who developed c-f antibodies by 1952, also developed neutralizing antibodies to a titer of more than 1:250 during the same period. Some children who failed to develop c-f antibodies, did develop neutralizing antibodies although of lower titer than found in children in whom c-f antibodies made their appearance. These findings are discussed in the light of theories regarding the mode of acquisition of antibodies to poliomyelitis virus.

Antibodies↗
PubMed1952

Levels of homotypic neutralizing antibody in human poliomyelitis three years after infection.

Quantitative neutralization tests in monkeys were carried out on sera obtained from 7 patients, 3 months, and 3 years after an attack of poliomyelitis. The serum specimens were tested against 100 to 1000 PD(50) of the patient's own strain of virus, recovered during the acute phase of the illness; all the strains were Type 1. The 6 patients, aged 6 months to 13 years, who had a paralytic attack of the disease, all exhibited very high levels of neutralizing antibody at 3 years as well as at 3 months after onset. The 50 per cent serum dilution titers ranged from about 1:180 to at least 1:860. Since the maximum titers were not established, it is not known to what extent, if any, the level of antibody may have dropped over the 3 year period. One of the patients, with a diagnosis of non-paralytic poliomyelitis, had a negligible or questionable antibody response during convalescence and no demonstrable antibody at 3 years; there is justifiable doubt as to whether the Type 1 poliomyelitis virus recovered from this patient had actually caused infection. Tests for Lansing neutralizing antibody indicated that the 5 patients who had no evidence of previous infection with Type 2 poliomyelitis virus had not become infected with it during the 3 year period. This suggested that these patients did not live in an environment in which infection with poliomyelitis virus is frequent. It is concluded, therefore, that in human beings, paralytic infections due to Type 1 poliomyelitis virus produce large amounts of homotypic neutralizing antibody, which persists at high levels for a period of at least 3 years.

Antibodies↗